17-17215203-G-C
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_144997.7(FLCN):c.1414C>G(p.Pro472Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,614,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P472L) has been classified as Likely benign.
Frequency
Consequence
NM_144997.7 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144997.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FLCN | NM_144997.7 | MANE Select | c.1414C>G | p.Pro472Ala | missense | Exon 12 of 14 | NP_659434.2 | ||
| FLCN | NM_001353229.2 | c.1468C>G | p.Pro490Ala | missense | Exon 14 of 16 | NP_001340158.1 | |||
| FLCN | NM_001353230.2 | c.1414C>G | p.Pro472Ala | missense | Exon 13 of 15 | NP_001340159.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FLCN | ENST00000285071.9 | TSL:1 MANE Select | c.1414C>G | p.Pro472Ala | missense | Exon 12 of 14 | ENSP00000285071.4 | ||
| ENSG00000264187 | ENST00000427497.3 | TSL:1 | n.*248C>G | non_coding_transcript_exon | Exon 8 of 12 | ENSP00000394249.3 | |||
| ENSG00000264187 | ENST00000427497.3 | TSL:1 | n.*248C>G | 3_prime_UTR | Exon 8 of 12 | ENSP00000394249.3 |
Frequencies
GnomAD3 genomes AF: 0.000716 AC: 109AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000215 AC: 54AN: 251400 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1461832Hom.: 0 Cov.: 34 AF XY: 0.0000660 AC XY: 48AN XY: 727208 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000729 AC: 111AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000832 AC XY: 62AN XY: 74478 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Birt-Hogg-Dube syndrome 1 Benign:1
This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance.
FLCN-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
not provided Benign:1
This variant is associated with the following publications: (PMID: 28873162)
Birt-Hogg-Dube syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at